Henry (Joe) Henk, serves as OptumLabs Vice President of Research/Principal Scientist and co-leads the OptumLabs Cancer Research Collaborative. Since joining Optum in 2004, his research has spanned a variety of diseases and treatment areas and has focused on therapy compliance, burden of illness, and cost comparisons, with focus on oncology and the use of biologics. Before joining OptumLabs, Joe served as Principal Consultant and Head of Optum’s Health Economics and Outcomes Research unit. Previously, Joe served as therapeutic lead for Oncology and Biologics, overseeing research, data acquisitions, and study execution in oncology and the use of biologic therapy. Joe earned his PhD in population health from the University of Wisconsin and a Master’s of Science in applied statistics from the University of Minnesota. Joe specializes in health economics, econometrics, and health outcomes with particular expertise in methods for working with observational data, population health, and health care expenditure.